Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 57 citing articles:

The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Opportunities and challenges for T cell-based influenza vaccines
Tim R. Mosmann, Andrew J. McMichael, Alexandre LeVert, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 10, pp. 736-752
Closed Access | Times Cited: 17
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Huajun Zhao, Xianyu Shao, Yating Yu, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
Colin A. Russell, Ron A. M. Fouchier, Parinaz Ghaswalla, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 13
Codon-optimization in gene therapy: promises, prospects and challenges
Anastasiia Iu. Paremskaia, Anna A. Kogan, А. А. Мурашкина, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 10
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial
Jintanat Ananworanich, Ivan T. Lee, David J. Ensz, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 9
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 8
mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020
James D. Allen, Ted M. Ross
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 5
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J. Maine, Shigeki J. Miyake-Stoner, Darina Spasova, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Cross Protection and Sustained Immunity Against Influenza a Viruses in Mice Provided by Core-Shell Structured Lipopolyplex Delivered mRNA Vaccine with Optimized Sequences Coding HAstem-Na-Fused Antigens
Tangqi Wang, Ruiwen Han, Hao Zhang, et al.
(2025)
Closed Access
mRNA vaccines: The new frontier
Zhipeng Yan, Ming Yang, E Tian, et al.
Elsevier eBooks (2025), pp. 669-683
Closed Access
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen
Meiou Liu, Yixuan Liu, Shaohui Song, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 91-91
Open Access
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview
Alex Boomgarden, Chitra Upadhyay
Vaccines (2025) Vol. 13, Iss. 2, pp. 148-148
Open Access
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults
Mieke Soens, Jintanat Ananworanich, Bryony Hicks, et al.
Vaccine (2025) Vol. 50, pp. 126847-126847
Closed Access
Induction of Enhanced Stem-directed Neutralizing Antibodies by HA2-16 Ferritin nanoparticles with H3 Influenza Virus Boost
Qingyu Wang, Jiaojiao Nie, Zejinxuan Liu, et al.
Nanoscale Advances (2025)
Open Access
A capless hairpin-protected mRNA vaccine encoding the full-length Influenza A hemagglutinin protects mice against a lethal Influenza A infection
Victor Solodushko, Jin H. Kim, Brian Fouty
Gene Therapy (2025)
Open Access
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
Zijing Wei, Shuai Zhang, Xingya Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice
Mingyang Li, Mengyuan Liu, Shaohui Song, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 300-300
Open Access | Times Cited: 4
Advances in Nucleic Acid Universal Influenza Vaccines
Liang Xu, Weigang Ren, Qin Wang, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 664-664
Open Access | Times Cited: 4
Engineering ionizable lipids for rapid biodegradation balances mRNA vaccine efficacy and tolerability
Julien Couture‐Senécal, Grayson Tilstra, Omar F. Khan
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top